Sharing below a fascinating article on obesity drugs.
The Race for the Next Ozempic | WIRED.
Interestingly, Eli Lilly’s tirzepatide is more promising than the semaglutide. And Neuland is developing it.
Just sharing.
I am invested and biased.
dr.vikas
| Subscribe To Our Free Newsletter |
